Trusted Resources: Education
Scientific literature and patient education texts
Iminosugar C-Glycosides Work as Pharmacological Chaperones of NAGLU, a Glycosidase Involved in MPS IIIB Rare Disease
source: Chemistry (Weinheim an der Bergstrasse, Germany)
year: 2021
authors: Zhu S,Jagadeesh Y,Tran AT,Imaeda S,Boraston A,Alonzi DS,Poveda A,Zhang Y,Désiré J,Charollais-Thoenig J,Demotz S,Kato A,Butters TD,Jiménez-Barbero J,Sollogoub M,Blériot Y
summary/abstract:Mucopolysaccharidosis type IIIB is a devastating neurological disease caused by a lack of the lysosomal enzyme, α-N-acetylglucosaminidase (NAGLU), leading to a toxic accumulation of heparan sulfate. Herein we explored a pharmacological chaperone approach to enhance the residual activity of NAGLU in patient fibroblasts. Capitalizing on the three-dimensional structures of two modest homoiminosugar-based NAGLU inhibitors in complex with bacterial homolog of NAGLU, CpGH89, we have synthesized a library of 17 iminosugar C-glycosides mimicking N-acetyl-D-glucosamine and bearing various pseudo-anomeric substituents of both α- and β-configuration. Elaboration of the aglycon moiety results in low micromolar selective inhibitors of human recombinant NAGLU, but surprisingly it is the non-functionalized and wrongly configured β-homoiminosugar that was proved to act as the most promising pharmacological chaperone, promoting a 2.4 fold activity enhancement of mutant NAGLU at its optimal concentration.
organization: Sorbonne Université, CNRS, Institut Parisien de Chimie Moléculaire, UMR 8232, 4 place Jussieu, 75005, Paris, France.DOI: 10.1002/chem.202101408
read more
Related Content
-
Significant Neuropsychiatric Symptoms: Three Mucopolysaccharidosis Type IIIB Cases, Two of Whom Were Siblings With a...Mucopolysaccharidosis (MPS) type IIIB pa...
-
Sanfilippo Syndrome Type B: Analysis of Patients Diagnosed By the MPS Brazil NetworkMucopolysaccharidosis type IIIB is a rar...
-
Schizophreniform Presentation and Abrupt Neurologic Decline in a Patient With Late-Onset Mucopolysaccharidosis Type ...Due to their low frequency and some atyp...
-
Which Is the Best Program for the Missense Variations in IDUA Gene? A Comparison of 33 Programs Plus a Conservation...Mucopolysaccharidosis type I (MPS I) is ...
-
Believe in G Golf TournamentGianna, was diagnosed with Sanfilippo Sy...
-
Europe Grants Orphan Drug Status to JR-441, ERT for Sanfilippo AThe European Commission has granted an o...
-
Experimental MPS 1 Therapy Shows Biomarker Activity, Improved FunctionREGENXBIO presented results from its ong...